Kayne Anderson Rudnick Investment Management
ISEE

Kayne Anderson Rudnick Investment Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-596
Closed -$23.4K – 908
2023
Q2 		$23.4K Hold
596
– – ﹤0.01% 550
2023
Q1 		$14.5K Hold
596
– – ﹤0.01% 553
2022
Q4 		$12.8K Buy
+596
New +$12.7K ﹤0.01% 569

Kayne Anderson Rudnick Investment Management's ISEE Position: Q3 2023 in Review

Kayne Anderson Rudnick Investment Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 596 shares — an estimated $23.4K sold.

Kayne Anderson Rudnick Investment Management first reported a position in ISEE in Q4 2022 and held it in 3 quarters. The position peaked at $23.4K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Kayne Anderson Rudnick Investment Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 596 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $23.4K.
  • Kayne Anderson Rudnick Investment Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Kayne Anderson Rudnick Investment Management's IVERIC bio, Inc. Common Stock position peaked at $23.4K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.